Inventor · disambiguated record
Guanglin Luo
Also filed as: LUO GUANGLIN
32 granted patents·5 pending applications·219 citations·filing 2000–2024
96Inventor score
Top patents by PatentIndex Score
37 records- 0197US9902722B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 27, 2018·19 cites·13 claims
- 0295US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0393US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0493US10550080B2Acyl sulfonamide NaV1.7 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 4, 2020·8 cites·9 claims
- 0592US10351563B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 16, 2019·3 cites·1 claims
- 0691US10155760B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 18, 2018·3 cites·4 claims
- 0791US8314117B2CGRP receptor antagonistsLUO GUANGLIN·Filed 2010·Granted Nov 20, 2012·23 cites·18 claims
- 0890US10752609B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 25, 2020·6 cites·10 claims
- 0990US10723734B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 28, 2020·2 cites·1 claims
- 1089US2024360131A1Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1188US8044043B2CGRP receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Oct 25, 2011·12 cites·21 claims
- 1288US7314883B2Anti-migraine treatmentsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jan 1, 2008·12 cites·36 claims
- 1388US6916812B2Alpha-aminoamide derivatives as melanocortin agonistsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 12, 2005·23 cites·7 claims
- 1488US6211225B1Heterocyclic aminopyrrolidine derivatives as melatonergic agentsBRISTOL MEYERS SQUIBB·Filed 2000·Granted Apr 3, 2001·44 cites·12 claims
- 1587US7842808B2Anti-migraine spirocyclesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 30, 2010·13 cites·36 claims
- 1681US11440913B2Aminoimidazopyridazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 13, 2022·2 cites·14 claims
- 1780US9718804B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 1, 2017·5 cites·6 claims
- 1880US7569578B2Heterocyclic anti-migraine agentsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Aug 4, 2009·14 cites·31 claims
- 1979US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 2079US10544120B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·2 cites·3 claims
- 2179US7220862B2Calcitonin gene related peptide receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 22, 2007·11 cites·36 claims
- 2279US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2378US12065437B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 20, 2024·0 cites·4 claims
- 2478US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2577US8143403B2CGRP receptor antagonistsLEAHY DAVID K·Filed 2010·Granted Mar 27, 2012·3 cites·5 claims
- 2675US10981910B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 20, 2021·0 cites·2 claims
- 2771US10246469B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 2, 2019·1 cites·8 claims
- 2871US7470680B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 30, 2008·1 cites·9 claims
- 2970US7049323B2Amidoheterocycles as modulators of the melanocortin-4 receptorBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 23, 2006·2 cites·10 claims
- 3067US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 3153US11053258B2Pyrimidine carboxamides as GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 6, 2021·0 cites·9 claims
- 3250US2013053570A1CGRP Receptor AntagonistsBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 3348US12172975B21H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)BRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 24, 2024·0 cites·12 claims
- 3447US2004063735A1Calcitonin gene related peptide receptor antagonistsFiled 2003·Application pending·0 cites
- 3546US9809573B2Substituted pyridine derivatives useful as GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 7, 2017·0 cites·3 claims
- 3644US11618753B2Aminopyrrolotriazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 4, 2023·0 cites·9 claims
- 3743US8748429B2CGRP receptor antagonistsLUO GUANGLIN·Filed 2012·Granted Jun 10, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Guanglin Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →